A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma
NCT07143812
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma (GBM)
Newly Diagnosed Glioblastoma Multiforme
Interventions
DRUG:
MSC11FCD
Sponsor
CHA University